Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
June 10, 2026 Drug delivery / Pharma applications / Uncategorized

Combined cyclodextrins and porphyrinoid derivatives in drug delivery systems

Porphyrins are powerful photosensitive molecules with useful photophysical and redox properties, making them attractive for therapeutic use. However, they often

Continue reading

June 9, 2026 Food / Non-pharma applications

Comparative Study of Nanosuspensions for Acetogenins Delivery

Researchers in Mexico compared two food-grade nanosuspension formulations for oral delivery of acetogenins (ACGs), a potent but poorly soluble class

Continue reading

June 8, 2026 Drug delivery / Pharma applications

Sustained transdermal delivery of insulin-cyclodextrin through the use of chitosan-based microneedle patches

Drug delivery using dissolving or biodegradable polymer microneedles has garnered significant interest in drug administration because of their biocompatibility, fast

Continue reading

June 10, 2026 Drug delivery / Pharma applications / Uncategorized

Combined cyclodextrins and porphyrinoid derivatives in drug delivery systems

Porphyrins are powerful photosensitive molecules with useful photophysical and redox properties, making them attractive for therapeutic use. However, they often

Continue reading

June 9, 2026 Food / Non-pharma applications

Comparative Study of Nanosuspensions for Acetogenins Delivery

Researchers in Mexico compared two food-grade nanosuspension formulations for oral delivery of acetogenins (ACGs), a potent but poorly soluble class

Continue reading

June 8, 2026 Drug delivery / Pharma applications

Sustained transdermal delivery of insulin-cyclodextrin through the use of chitosan-based microneedle patches

Drug delivery using dissolving or biodegradable polymer microneedles has garnered significant interest in drug administration because of their biocompatibility, fast

Continue reading

June 5, 2026 Non-pharma applications / Pharma applications

Events of American Cyclodextrin Consortium

Virtual Meeting Jun 25, 2026, 10:00 AM – 11:00 AM PDT Zoom: https://us02web.zoom.us/j/86748849340 Virtual meetings are held quarterly. The next

Continue reading

June 4, 2026 Pharma applications

Ultrafast-dissolving ocular microneedle patch with voriconazole-cyclodextrin complex

Fungal keratitis (FK) is a leading cause of corneal blindness worldwide. Although voriconazole (VOR) is effective, its poor corneal permeability

Continue reading

June 3, 2026 CD as API / CD derivatives / Drug delivery / Pharma applications

Nano-Enabled Toxicity of Pharmaceutical Excipients

Nanotechnology has brought revolutionary advances in the pharmaceutical field. Among drug delivery systems, nanocarriers, which enhance the solubility, stability and

Continue reading

left human eye
June 2, 2026 Cosmetics and toilettry / Non-pharma applications

Cyclodextrins Across the Eye-Care Spectrum

When people talk about innovative eye-care products, the spotlight usually goes to ingredients like hyaluronic acid, panthenol, collagen, botanical extracts

Continue reading

June 1, 2026 Drug delivery / Pharma applications

Biphasic dissolving microneedles with cyclodextrin inclusion complexes for enhanced delivery of poorly soluble drugs

Dissolving microneedles (DMNs) have been widely investigated for transdermal drug delivery, yet their clinical translation and commercialization remain limited, primarily

Continue reading

May 29, 2026 Drug delivery / Pharma applications / Uncategorized

CD-based supramolecular polymers based on host–guest interactions for cancer therapy

Cyclodextrin-based supramolecular polymers (SPCDs) have emerged as promising platforms for cancer therapy via the utilization of cyclodextrin (CD)-mediated host-guest interactions

Continue reading

May 28, 2026 CD derivatives / Drug delivery / Pharma applications / Uncategorized

PEG-β-Cyclodextrin polymer-based formulation to increase the antiangiogenic activity of rutin in vivo

Rutin (RTN) is a natural flavonoid with well-documented anti-angiogenic, antioxidant, anti-inflammatory, and anti-cancer properties. However, its therapeutic potential is limited

Continue reading

Posts pagination

1 2 3 … 199 Next Posts»

Recent Posts

  • Combined cyclodextrins and porphyrinoid derivatives in drug delivery systems
  • Comparative Study of Nanosuspensions for Acetogenins Delivery
  • Sustained transdermal delivery of insulin-cyclodextrin through the use of chitosan-based microneedle patches
  • Events of American Cyclodextrin Consortium
  • Ultrafast-dissolving ocular microneedle patch with voriconazole-cyclodextrin complex

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (66)
  • CD as API (347)
  • CD derivatives (410)
  • Cosmetics and toilettry (51)
  • Diagnosis (12)
  • Drug delivery (792)
  • E-ducation (63)
  • Environmental (134)
  • Events (234)
  • Food (222)
  • Gene delivery (20)
  • Household products (1)
  • Household products (4)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (400)
  • Other industrial use (106)
  • Pharma applications (1,184)
  • Supramolecular systems (40)
  • Uncategorized (147)

Top Posts

  • Comparative Study of Nanosuspensions for Acetogenins Delivery
  • Polyphenols' encapsulation in cyclodextrins: An updated systematic literature review
  • Combined cyclodextrins and porphyrinoid derivatives in drug delivery systems
  • Ultrafast-dissolving ocular microneedle patch with voriconazole-cyclodextrin complex
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • Sustained transdermal delivery of insulin-cyclodextrin through the use of chitosan-based microneedle patches
  • Harnessing Organoid Platforms for Nanoparticle Drug Development
  • A review on sodium sulfobutylether-β-cyclodextrin (SBECD)
  • A new multi-compendia modified beta-cyclodextrin, Kleptose® HPB-LB parenteral grade
  • A sugammadex-analogue, per-6-O-carboxyhexyl-thio-gamma-CD (OKL-1111) is a highly potent and universal reversal agent for anticoagulants

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,473 other subscribers

Loading Comments...